| | | | | | | | | | |
|
|
| Dockets Entered
On December 10, 2003
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1978N-0036L
|
| OTC Laxative
|
|
|
| 1980A-0209
|
| Legal Name for Ice Cream Products
|
|
|
| 1981P-0306
|
| RECLASS PETITION 513(F) PROPHYLACTIC W/ SPERMICIDAL LUBRI
|
|
|
| 1995S-0117
|
| Human Drugs Patent Term Extension & New Patents
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2001P-0546
|
| ANDA for Covera-HS
|
|
|
| 2003D-0385
|
| Guidance for Industry: Comparability Protocols - Protein Drug Products and Biologic Products - Chemistry, Manufacturing, and Controls Information
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| 2003N-0338
|
| Obesity
|
|
|
| 2003N-0344
|
| Consumer-Directed Promotion; Public Meeting
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
| 2003N-0422
|
| Annual Stakeholder Meeting on the Implementation of MDUFMA Provisions
|
|
|
| 2003N-0456
|
| Agency Information Collection:Prevention of Medical Gas Mix-ups at Health Care Facilities
|
|
|
| 2003N-0470
|
| Preparation for ICH meetings and ICH 6 Conference in Osaka, Japan, November 9-15, 2003: Public Meeting
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
| 2003P-0278
|
| Regulate recombinant and any other previously unlicensed endotoxin detection tests for validation, in-process and finished product endotoxin testing od drugs
|
|
|
| 2003P-0280
|
| Determine that a recombinanat endotoxin tests intended for endotoxin testing of human drugs and medical devices
|
|
|
| 2003P-0398
|
| (ANDA) for Oral Capsule Dosage Form Containing Hydrocodone Bitartrate 5 mg/Butalbital 50 mmg/ Cafferine 40mg/ Acetaminophen 325mg
|
|
|
| 2003P-0469
|
| ANADA Suitability for Ivermectin Hard-Chew Anthelmintic for (non-food) Horses
|
|
|
| 2003P-0523
|
| ANADA Suitability Petition for Ivermectin/Praziquantel Granule/Crumble Anthelmintic for Horses
|
|
|
| 2003P-0530
|
| Silicone Gel-filled Breast Implants
|
|
|
| 2003P-0552
|
| ANADA for a generic new animal drug caroprofen
|
|
|
| 2003P-0555
|
| Maintain the Electroconvulsive Therapy Device in Class III for All Indications
|
|
|
| 2003Q-0547
|
| Health Claim Notification: Whole Grains and Coronary Heart Disease
|
|
|
| 1978N-0036L
|
| OTC Laxative
|
|
|
| ACK
29
|
| HFA-305 to CIBA Consumer Pharmaceuticals
|
| Vol #:
|
| 69
|
|
|
| 1980A-0209
|
| Legal Name for Ice Cream Products
|
|
|
| ACK
1
|
| HFA-305 to Flavor & Extract Manufacturers
|
| Vol #:
|
| 1
|
|
|
| LET
16
|
| Bureau of Food
|
| Vol #:
|
| 1
|
|
|
| SUP
2
|
| National Food Inccredient Co
|
| Vol #:
|
| 1
|
|
|
| 1981P-0306
|
| RECLASS PETITION 513(F) PROPHYLACTIC W/ SPERMICIDAL LUBRI
|
|
|
| ACK
1
|
| HFA-305 to Schmid Products Co.
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| ACK 2
|
| Hamel, Park, McCabe & Saunders
|
| Vol #:
|
| 1
|
|
|
| 1995S-0117
|
| Human Drugs Patent Term Extension & New Patents
|
|
|
| LST 88
|
| List as of December 3, 2003
|
| Vol #:
|
| 7
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
11889
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 93
|
|
|
| LET
11890
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 93
|
|
|
| LET
11891
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 93
|
|
|
| LET
11892
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 93
|
|
|
| LET
11893
|
| Cognis Corporation
|
| Vol #:
|
| 93
|
|
|
| LET
11894
|
| Food Science of Vermont
|
| Vol #:
|
| 93
|
|
|
| LET
11895
|
| Food Science of Vermont
|
| Vol #:
|
| 93
|
|
|
| LET
11896
|
| Food Science of Vermont
|
| Vol #:
|
| 93
|
|
|
| LET
11897
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 93
|
|
|
| LET
11898
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 93
|
|
|
| LET
11899
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 93
|
|
|
| LET
11900
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 93
|
|
|
| LET
11901
|
| Patent Health, LLC
|
| Vol #:
|
| 94
|
|
|
| LET
11902
|
| Marco Polo Technologies,Inc
|
| Vol #:
|
| 94
|
|
|
| LET
11903
|
| Solstice Medicine Company
|
| Vol #:
|
| 94
|
|
|
| LET
11904
|
| Solstice Medicine Company
|
| Vol #:
|
| 94
|
|
|
| LET
11905
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 94
|
|
|
| LET
11906
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 94
|
|
|
| LET
11907
|
| Intetrative Therapeutics Inc.
|
| Vol #:
|
| 94
|
|
|
| LET
11908
|
| Reliance Vitamin Company, Inc.
|
| Vol #:
|
| 94
|
|
|
| LET
11909
|
| Nature's Way Products, Inc.
|
| Vol #:
|
| 94
|
|
|
| LET
11910
|
| Synergy Worldwide
|
| Vol #:
|
| 94
|
|
|
| LET
11911
|
| Botanical Solutions, Inc.
|
| Vol #:
|
| 94
|
|
|
| LET
11912
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 94
|
|
|
| LET
11913
|
| MACA US Sales
|
| Vol #:
|
| 94
|
|
|
| LET
11914
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 94
|
|
|
| LET
11915
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 94
|
|
|
| LET
11916
|
| Gaia Herbs
|
| Vol #:
|
| 94
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| C 7305
|
| Doris Belanger
|
| Vol #:
|
| 305
|
|
|
| C 7306
|
| Barbara Kwasnik
|
| Vol #:
|
| 305
|
|
| | | | | | | | |
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| C
303
|
| American Academy of Pediatrics (AAP) & Society for Adolescent Medicine (SAM)
|
| Vol #:
|
| 39
|
|
|
| C
304
|
| National Partnership for Women & Families
|
| Vol #:
|
| 39
|
|
|
| C
305
|
| Texas Campaign for Emergency Contraception
|
| Vol #:
|
| 39
|
|
|
| C
306
|
| Emergency Contraception Access Campaign
|
| Vol #:
|
| 305
|
|
|
| TS
1
|
| National Campaign to Prevent Teen Pregnancy
|
| Vol #:
|
| 39
|
|
|
| TS
2
|
| National Latina Institute for Reproductive Health (NLIRH)
|
| Vol #:
|
| 39
|
|
|
| TS
3
|
| Physicians for Reproductive Choice and Health (PRCH)
|
| Vol #:
|
| 39
|
|
|
| TS
4
|
| National Family Planning and Reproductive Health Assn (NFPRHA)
|
| Vol #:
|
| 39
|
|
|
| 2001P-0546
|
| ANDA for Covera-HS
|
|
|
| PDN
1
|
| HF-22 to Morgan, Lewis & Bockius LLP
|
| Vol #:
|
| 3
|
|
|
| 2003D-0385
|
| Guidance for Industry: Comparability Protocols - Protein Drug Products and Biologic Products - Chemistry, Manufacturing, and Controls Information
|
|
|
| C
7
|
| The Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| Vol #:
|
| 1
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| C
7
|
| Pamlab, LLC
|
| Vol #:
|
| 1
|
|
|
| C
8
|
| International Guai-Support Group Network
|
| Vol #:
|
| 1
|
|
|
| C
9
|
| International Guai-Support Group Network
|
| Vol #:
|
| 1
|
|
|
| C
10
|
| International Guai-Support Group Network
|
| Vol #:
|
| 1
|
|
|
| 2003N-0338
|
| Obesity
|
|
|
| EC 95
|
| Peaslee, Kindy
|
| Vol #:
|
| 7
|
|
|
| EMC
40
|
| Enig Associates, Inc
|
| Vol #:
|
| 7
|
|
|
| EMC
41
|
| Grocery Manufacturers of America
|
| Vol #:
|
| 7
|
|
|
| TR 3
|
| Transcript of the November 20,
2003 Meeting
|
| Vol #:
|
| 9
|
|
|
| 2003N-0344
|
| Consumer-Directed Promotion; Public Meeting
|
|
|
| C
3
|
| National Assn of Boards of Pharmacy (NABP)
|
| Vol #:
|
| 3
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
| C 25
|
| Allison J. Maffucci
|
| Vol #:
|
| 3
|
|
|
| C 26
|
| Allison J. Maffucci
|
| Vol #:
|
| 3
|
|
|
| C
27
|
| Exotic Pet and Bird Clinic
|
| Vol #:
|
| 3
|
|
|
| C
28
|
| Georgia Department of Natural
Resources (GADNR)
|
| Vol #:
|
| 3
|
|
|
| C 29
|
| Maureen C. McDonald
|
| Vol #:
|
| 3
|
|
|
| C 30
|
| Dianne James
|
| Vol #:
|
| 3
|
|
|
| C 31
|
| Robert G. Weiner
|
| Vol #:
|
| 3
|
|
| | | | | | | | |
|
|
| C
32
|
| Form Letters
|
| Vol #:
|
| 4
|
|
|
| 2003N-0422
|
| Annual Stakeholder Meeting on the Implementation of MDUFMA Provisions
|
|
|
| TS 1
|
| AdvaMed
|
| Vol #:
|
| 1
|
|
|
| TS
2
|
| National Electronical Manufacturers Association
|
| Vol #:
|
| 1
|
|
|
| TS
3
|
| Center for Patient Advocacy
|
| Vol #:
|
| 1
|
|
|
| TS
4
|
| Center for Patient Advocacy
|
| Vol #:
|
| 1
|
|
|
| 2003N-0456
|
| Agency Information Collection:Prevention of Medical Gas Mix-ups at Health Care Facilities
|
|
|
| C
1
|
| Compressed Gas Assn (CGA)
|
| Vol #:
|
| 1
|
|
|
| 2003N-0470
|
| Preparation for ICH meetings and ICH 6 Conference in Osaka, Japan, November 9-15, 2003: Public Meeting
|
|
|
| TR
1
|
| Transcript of the November 3, 2003 meeting
|
| Vol #:
|
| 2
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
| LET
2
|
| HFS-800 to Compassion Over Killing, Inc
|
| Vol #:
|
| 6
|
|
|
| 2003P-0278
|
| Regulate recombinant and any other previously unlicensed endotoxin detection tests for validation, in-process and finished product endotoxin testing od drugs
|
|
|
| LET
1
|
| HFM-1 to Hyman, Phelps & McNamara
|
| Vol #:
|
| 1
|
|
|
| 2003P-0280
|
| Determine that a recombinanat endotoxin tests intended for endotoxin testing of human drugs and medical devices
|
|
|
| LET
1
|
| HFM-1 to Hyman, Phelps & McNamara, PC
|
| Vol #:
|
| 1
|
|
|
| 2003P-0398
|
| (ANDA) for Oral Capsule Dosage Form Containing Hydrocodone Bitartrate 5 mg/Butalbital 50 mmg/ Cafferine 40mg/ Acetaminophen 325mg
|
|
|
| C
1
|
| King & Spalding, LLP
|
| Vol #:
|
| 1
|
|
|
| 2003P-0469
|
| ANADA Suitability for Ivermectin Hard-Chew Anthelmintic for (non-food) Horses
|
|
|
| PAV
1
|
| HFV-100 to Eugene G. Keller,RPh.,FACA
|
| Vol #:
|
| 1
|
|
|
| 2003P-0523
|
| ANADA Suitability Petition for Ivermectin/Praziquantel Granule/Crumble Anthelmintic for Horses
|
|
|
| PAV
1
|
| HFV-100 to Karen A. Sisson
|
| Vol #:
|
| 1
|
|
|
| 2003P-0530
|
| Silicone Gel-filled Breast Implants
|
|
|
| C
1
|
| Inamed Corporation (Inamed)
|
| Vol #:
|
| 1
|
|
|
| CR
1
|
| King & Spalding
|
| Vol #:
|
| 1
|
|
|
| 2003P-0552
|
| ANADA for a generic new animal drug caroprofen
|
|
|
| ACK
1
|
| HFA-305 to Jurox PTY, Limited
|
| Vol #:
|
| 1
|
|
|
| CP
1
|
| Jurox PTY, limited
|
| Vol #:
|
| 1
|
|
|
| 2003P-0555
|
| Maintain the Electroconvulsive Therapy Device in Class III for All Indications
|
|
| | | | | | | | |
|
|
| ACK 1
|
| HFA-305 to Committee for Truth in Psychiatry
|
| Vol #:
|
| 1
|
|
|
| CP
1
Attachment
|
| Committee for Truth in Psychiatry
|
| Vol #:
|
| 1
|
|
|
| 2003Q-0547
|
| Health Claim Notification: Whole Grains and Coronary Heart Disease
|
|
|
| ACK
1
|
| HFS-306 to Kraft Foods North America, Inc
|
| Vol #:
|
| 2
|
|
|
| HCN
1
Appendix
a, b, c,
d
|
| Kraft Foods North America, Inc.
|
| Vol #:
|
| 1
|
|
|
| HCN
2
Attachment, Appendix
a, b, c, d
|
| Kraft Foods North America, Inc.
|
| Vol #:
|
| 3
|
|
|
| LET
1
|
| HFS-800 to National Academy of Science
|
| Vol #:
|
| 2
|
|
|
| LET
2
|
| Kraft Foods North America, Inc.
|
| Vol #:
|
| 2
|
|
|